Abstract:Recent evidence suggests that the human kallikrein 10 (KLK10) gene is differentially regulated in endocrine-related tumors and has potential as diagnostic and/or prognostic marker; however, KLK10 expression has never been investigated in gastrointestinal cancers. The aims of this study were to demonstrate expression and single nucleotide polymorphisms of KLK10 in colorectal cancer (CRC) and gastric cancer (GC), and to correlate the relative KLK10 expression level with clinicopathological factors of CRC and GC. Between March 2004 and January 2005, 63 patients with histologically confirmed CRC and 36 with GC were recruited into the study. Using quantitative real-time (qRT) RT-PCR and Western blot, KLK10 expression in tumor and non-tumor colorectal and gastric tissues was determined at the mRNA and protein levels. KLK10 protein was localized by immunohistochemistry. The KLK10 genomic DNA from 16 cases of paired normal/cancerous colorectal tissues was PCR-amplified and examined for single nucleotide polymorphisms by direct sequencing. KLK10 mRNA expression was detected by qRT in 61 of 63 (96.8%) CRC specimens and in all GC specimens. KLK10 expression was much higher in tumor tissue than in the corresponding normal mucosal tissue at the mRNA and protein levels (P < 0.01). The KLK10 mRNA expression level significantly correlated with lymphatic invasion (P = 0.034) and clinical stage of CRC (P = 0.025). The KLK10 mRNA expression level significantly correlated with the depth of GC invasion (P = 0.018), clinical stage (P = 0.045), patient sex (P = 0.027) and Lauren type of gastric cancer (P = 0.028). No mutations or polymorphisms were detected in exon 1, 2 and 5 of KLK10 gene in CRC. Single nucleotide polymorphisms were identified in codon 50 of exon 3, GCC (alanine) to TCC (serine). The genetic changes of exon 4 were located at codon 106 [GGC (glysine) to GGA (glysine)], codon 112 [ACG (threonine) to ACC (threonine)], codon 141 [CTA (leucine) to CTG (leucine)], and codon 149 [CCG (proline) to CTG (leucine)]. All were identical in tumor and corresponding normal tissue DNA from the same individuals. KLK10 expression is up-regulated in CRC and GC and higher expression of KLK10 closely correlates with advanced disease stage, which predicts a poorer prognosis; however, further follow-up study is needed.

Down-regulation of Kallikrein in Prostate Cancer

Expression of Kallikrein-Related Peptidase 7 is Decreased in Prostate Cancer

Stromal Cells Inhibit Kallikrein 7 Expression in the Epithelial Cells of Benign Prostate Hyperplasia

Expression of DLK1 Protein and Its Correlation with Renal Cell Carcinoma Pathological Characteristics

Human Kallikrein 7 Induces Epithelial-Mesenchymal Transition-like Changes in Prostate Carcinoma Cells: A Role in Prostate Cancer Invasion and Progression

Kallikrein 4 is a Predominantly Nuclear Protein and is Overexpressed in Prostate Cancer

Establishment of a human prostatic carcinoma cell line stably overexpressing Kallikrein 7

KLK31P is a Novel Androgen Regulated and Transcribed Pseudogene of Kallikreins That is Expressed at Lower Levels in Prostate Cancer Cells Than in Normal Prostate Cells

Elementary Research on Clinical Significance of Human Tissue Kallikrein Gene 5 Expression in Breast Cancer Tissues

[Expression of KLK6 Protein and Mrna in Primary Breast Cancer and Its Clinical Significance].

Human Kallikrein 2 (KLK2) Promotes Prostate Cancer Cell Growth Via Function As a Modulator to Promote the ARA70-enhanced Androgen Receptor Transactivation.

Human kallikrein 2 and prostate cancer

Clinical significance of human KLK8 gene expression in breast cancer

Downregulation of Krüppel-like factor 9 in human colorectal cancer.

Expression of P27kip1 and CDKs in Prostate Carcinoma and Benign Prostate Hyperplasia Tissues

KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors

Immunohistochemical expression of kallikrein 7 in oral squamous cell carcinoma

Expression and significance of clusterin in normal prostate, benign prostate hyperplasia and prostate cancer

Kallikrein 4 is a Proliferative Factor That is Overexpressed in Prostate Cancer.

Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.

Kallikreins are involved in an miRNA network that contributes to prostate cancer progression.